GSK and Shenzhen Neptunus in £52 million flu vaccine joint venture
10 June 2009
Sita Shah
Please Login to read the full article.
10 June 2009
Sita Shah
sita.shah@informa.com
GlaxoSmithKline and Shenzhen Neptunus of China are to invest £52 million in a new joint venture to develop and manufacture influenza vaccines in China. GSK has an established business in China, but the alliance represents its first move into the Chinese influenza vaccines market.
GSK...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Asia Beat: Rising China vaccines tide to lift all boats
- 2011 Scrip Asia 100 - Flexibility the key to riding Asia's emerging giants
- Weaker private equity in India for 2012, portfolios turning 'a la carte'
- Broad swathe of measures to support UK life sciences draws widespread applause
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
